As far as industries go, few are quite as complex, multifaceted, and, as T. Rowe Price Health Sciences fund portfolio manager Ziad Bakri puts it, “idiosyncratic” as health care. The sector spans the gamut from drugs and devices that can produce biological miracles to the actuarial business of insurance. Oh, and it just happens to be one of the nation’s most-battered political piñatas.

Source: Best Stocks 2018: 4 Biotech and Healthcare Stocks to Buy Now | Fortune

Comments are closed.